{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:57:21Z","timestamp":1760608641732,"version":"3.38.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.npep.2011.03.004","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T04:23:21Z","timestamp":1303705401000},"page":"219-227","source":"Crossref","is-referenced-by-count":10,"title":["Multiple opioid receptors mediate the hypotensive response induced by central 5-HT3 receptor stimulation"],"prefix":"10.1016","volume":"45","author":[{"given":"J.B.","family":"Fregoneze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.F.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.F.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"De Castro e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2011.03.004_b0005","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.peptides.2009.09.027","article-title":"Endogenous opiates and behavior: 2008","volume":"30","author":"Bodnar","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.expneurol.2007.09.028","article-title":"Beta-Endorphin in the median preoptic nucleus modulates the pressor response induced by subcutaneous hypertonic sodium chloride","volume":"210","author":"Caeiro","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2011.03.004_b0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-3565(24)29577-X","article-title":"Blockade of delta opioid receptors in the ventrolateral periaqueductal gray region inhibits the fall in arterial pressure evoked by hemorrhage","volume":"297","author":"Cavun","year":"2001","journal-title":"Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2011.03.004_b0025","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0196-9781(97)00210-6","article-title":"Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse","volume":"18","author":"Champion","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0030","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1016\/S0893-133X(99)00008-1","article-title":"Serotonin and stress","volume":"21","author":"Chaouloff","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2011.03.004_b0035","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0024-3205(91)90154-4","article-title":"Opioid receptor-coupled second messenger systems","volume":"48","author":"Childers","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2011.03.004_b0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/FPC.0b013e328322e73d","article-title":"From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics","volume":"19","author":"Chu","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.npep.2011.03.004_b0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1476-5381.1963.tb01302.x","article-title":"A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine","volume":"20","author":"Corne","year":"1963","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.npep.2011.03.004_b0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0773.1992.tb00448.x","article-title":"Anxiolytic potential of 5-HT3 receptor antagonists","volume":"70","author":"Costall","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.npep.2011.03.004_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1568007043482624","article-title":"5-HT3 receptors","volume":"3","author":"Costall","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.npep.2011.03.004_b0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molmed.2004.03.007","article-title":"Recent advances in understanding serotonin regulation of cardiovascular function","volume":"10","author":"C\u00f4t\u00e9","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.npep.2011.03.004_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2006.09.008","article-title":"Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS","volume":"144","author":"D\u2019Addario","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2011.03.004_b0070","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.81.9.2898","article-title":"Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo","volume":"81","author":"D\u2019Amato","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2011.03.004_b0075","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.2001.81.4.1599","article-title":"The hypothalamus and hypertension","volume":"81","author":"De Wardener","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2011.03.004_b0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0278-5846(01)00161-0","article-title":"Role of endogenous opioid system in the regulation of the stress response","volume":"25","author":"Drolet","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2011.03.004_b0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1476-5381.1983.tb10547.x","article-title":"Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors","volume":"109","author":"Faden","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2011.03.004_b0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(95)01434-9","article-title":"Cardiovascular effects of Leu-enkephalin in the nucleus tractus solitarius of the rat","volume":"709","author":"Feldman","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2004.08.063","article-title":"Role of central 5-HT3 receptors in the control of blood pressure in stressed and non-stressed rats","volume":"1028","author":"Ferreira","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2005.01.054","article-title":"Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats","volume":"1040","author":"Ferreira","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0105","first-page":"I125","article-title":"The opioid system in cardiac and vascular regulation of normal and hypertensive states","volume":"75","author":"Feuerstein","year":"1987","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2011.03.004_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0196-9781(88)90227-6","article-title":"Hypothalamic mu-opioid receptors in cardiovascular control: a review","volume":"9","author":"Feuerstein","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/pr.59.1.3","article-title":"The endomorphin system and its evolving neurophysiological role","volume":"59","author":"Fichna","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2011.03.004_b0120","series-title":"Textbook of Pain","first-page":"243","article-title":"Central nervous system mechanisms of pain modulation","author":"Fields","year":"1994"},{"key":"10.1016\/j.npep.2011.03.004_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1748-1716.2007.01720.x","article-title":"Central inhibition of opioid receptor subtypes and its effect on haemorrhagic hypotension in conscious sheep","volume":"191","author":"Frithiof","year":"2007","journal-title":"Acta Physiol."},{"key":"10.1016\/j.npep.2011.03.004_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1098-1128(199703)17:2<163::AID-MED2>3.0.CO;2-Y","article-title":"Serotonin 5-HT3 and 5-HT4 receptor antagonists","volume":"17","author":"Gaster","year":"1997","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.npep.2011.03.004_b0135","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1006\/bbrc.1994.2826","article-title":"Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain","volume":"205","author":"George","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2011.03.004_b0140","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0024-3205(87)90611-4","article-title":"Naloxone reverses the serotonin dependent hypotensive action of CGP 6085 A","volume":"41","author":"Goldstein","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2011.03.004_b0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00003495-199855020-00002","article-title":"5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy","volume":"55","author":"Gregory","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.npep.2011.03.004_b0150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1440-1681.2002.03636.x","article-title":"Opioid signalling in the rat rostral ventrolateral medulla","volume":"29","author":"Guyenet","year":"2002","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.npep.2011.03.004_b0155","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/j.1552-4604.1995.tb04129.x","article-title":"5-HT3 receptors: pharmacologic and therapeutic aspects","volume":"35","author":"Gyermek","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.npep.2011.03.004_b0160","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/BF02245009","article-title":"Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse","volume":"112","author":"Hagan","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.npep.2011.03.004_b0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00001756-200204160-00038","article-title":"Delta- and kappa-opioid receptors in the caudal midline medulla mediate haemorrhage-evoked hypotension","volume":"13","author":"Henderson","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.npep.2011.03.004_b0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.pa.23.040183.002545","article-title":"Cardiovascular effects of endogenous opiate systems","volume":"23","author":"Holaday","year":"1983","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.npep.2011.03.004_b0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0033-0620(85)90004-0","article-title":"The cardiovascular actions of morphine and the endogenous opioid peptides","volume":"27","author":"Johnson","year":"1985","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.npep.2011.03.004_b0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-8993(97)00285-0","article-title":"Cardiovascular effects of microinjections of opioid agonists into the \u2018Depressor Region\u2019 of the ventrolateral periaqueductal gray region","volume":"762","author":"Keay","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(97)00988-8","article-title":"Quantitative autoradiographic mapping of \u03bc-, \u03b4- and \u03ba-opioid receptors in knockout mice lacking the \u03bc-opioid receptor gene","volume":"778","author":"Kitchen","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.npep.2011.03.004_b0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.npep.2006.05.001","article-title":"Role of limbic peptidergic circuits in regulation of arterial pressure, relevant to development of essential hypertension","volume":"40","author":"Ku","year":"2006","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2011.03.004_b0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/08990229209144768","article-title":"The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat","volume":"9","author":"Kwiat","year":"1992","journal-title":"Somatosens. Mot. Res."},{"key":"10.1016\/j.npep.2011.03.004_b0200","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.neubiorev.2008.04.006","article-title":"Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders","volume":"32","author":"Lanfumey","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2011.03.004_b0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/10641968209061589","article-title":"Opioid peptides and blood pressure regulation","volume":"4","author":"Lang","year":"1982","journal-title":"Clin. Exp. Hypertens. A"},{"key":"10.1016\/j.npep.2011.03.004_b0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(77)90146-7","article-title":"Central cardiovascular effects of morphinomimetic peptides in dogs","volume":"46","author":"Laubie","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2011.03.004_b0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.npep.2011.03.004_b0220","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.2042-7158.1998.tb03322.x","article-title":"Effects of rat brain kappa 1- and kappa 2-opioid receptors after chronic treatment with non-peptide kappa-agonists","volume":"50","author":"McConnaughey","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.npep.2011.03.004_b0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0079-6123(08)60201-0","article-title":"Neuropeptides and neurotransmitters involved in regulation of corticotropin-releasing factor-containing neurons in the rat","volume":"72","author":"Mezey","year":"1987","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0306-4522(01)00439-0","article-title":"Activation of mu-opioid receptors in rat ventrolateral medulla selectively blocks baroreceptor reflexes while activation of delta opioid receptors blocks somato-sympathetic reflexes","volume":"109","author":"Miyawaki","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2011.03.004_b0235","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1440-1681.1990.tb01353.x","article-title":"A lack of potency for the delta-opioid antagonist naltrindole after microinjection into the rostral ventrolateral medulla of rabbits","volume":"17","author":"Morilak","year":"1990","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.npep.2011.03.004_b0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neubiorev.2008.05.026","article-title":"Central 5-HT receptors in cardiovascular control during stress","volume":"33","author":"Nalivaiko","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2011.03.004_b0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2006.09.029","article-title":"Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice","volume":"552","author":"Nozaki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2011.03.004_b0250","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0196-9781(98)00137-5","article-title":"Endogenous opiates: 1997","volume":"19","author":"Olson","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0255","first-page":"243","article-title":"The design of delta-selective opioid receptor antagonists","volume":"48","author":"Portoghese","year":"1993","journal-title":"Farmaco"},{"key":"10.1016\/j.npep.2011.03.004_b0260","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2011.03.004_b0265","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1021\/jm00168a028","article-title":"Design of peptidomimetic delta opioid receptor antagonists using the message-address concept","volume":"33","author":"Portoghese","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2011.03.004_b0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0163-7258(02)00165-1","article-title":"The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system","volume":"93","author":"Pugsley","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.npep.2011.03.004_b0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0361-9230(01)00612-8","article-title":"Central cardiovascular regulation and 5-hydroxytryptamine receptors","volume":"56","author":"Ramage","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2011.03.004_b0280","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tips.2008.06.009","article-title":"5-Hydroxytryptamine and cardiovascular regulation","volume":"29","author":"Ramage","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.npep.2011.03.004_b0285","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0196-9781(03)00122-0","article-title":"Cardiovascular responses to central administration of mu and kappa opioid receptor agonist and antagonist in normal rats","volume":"24","author":"Rao","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cne.902420405","article-title":"Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla","volume":"245","author":"Ross","year":"1985","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2011.03.004_b0295","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0196-9781(89)90135-6","article-title":"Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography species differences and comparison with kappa receptors","volume":"10","author":"Sharif","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0022-3565(25)10324-8","article-title":"Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain","volume":"263","author":"Schoffelmeer","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2011.03.004_b0305","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bst0200449","article-title":"Regulation of brain neurotransmitter release and of adenylate cyclase activity by opioid receptors","volume":"20","author":"Schoffelmeer","year":"1992","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.npep.2011.03.004_b0310","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1476-5381.1991.tb12464.x","article-title":"The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E\u2013115 neuroblastoma cells","volume":"104","author":"Sep\u00falveda","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2011.03.004_b0315","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1523\/JNEUROSCI.12-04-01335.1992","article-title":"Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: multiple substrates for opiate-dopamine interactions","volume":"12","author":"Sesack","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2011.03.004_b0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-0102(92)90080-V","article-title":"Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique","volume":"14","author":"Sharma","year":"1992","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.npep.2011.03.004_b0325","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004872-199917040-00007","article-title":"Comparison of cardiovascular responses to intra-hippocampal mu, delta and kappa opioid agonists in spontaneously hypertensive rats and isolation-induced hypertensive rats","volume":"17","author":"Shen","year":"1999","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2011.03.004_b0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2007.05.006","article-title":"Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors","volume":"1158","author":"Song","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0335","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0361-9230(97)00453-X","article-title":"Further characterization of forebrain serotonin receptors mediating tachycardia in conscious rats","volume":"45","author":"Szab\u00f3","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2011.03.004_b0340","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)21011-4","article-title":"Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays","volume":"246","author":"Takemori","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2011.03.004_b0345","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.2174\/138161206778522029","article-title":"5-HT3 receptors","volume":"12","author":"Thompson","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2011.03.004_b0350","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-8993(96)01261-9","article-title":"Cyclo(Gly-Gln) inhibits the cardiorespiratory depression produced by beta-endorphin and morphine","volume":"747","author":"Unal","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2011.03.004_b0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.autneu.2010.07.028","article-title":"Blockade of 5-HT(3) receptors at septal area increase blood pressure in unanaesthetized rats","volume":"159","author":"Urzedo-Rodrigues","year":"2011","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.npep.2011.03.004_b0360","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0196-9781(01)00566-6","article-title":"Endogenous opiates: 2000","volume":"22","author":"Vaccarino","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0365","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0196-9781(99)00166-7","article-title":"Endogenous opiates: 1998","volume":"20","author":"Vaccarino","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2011.03.004_b0370","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10799899709036608","article-title":"Full and partial agonists induce distinct desensitized states of the 5-HT3 receptor","volume":"17","author":"Van Hooft","year":"1997","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.npep.2011.03.004_b0375","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0028-3908(80)90131-8","article-title":"Head twitches induced by LSD and quipazine: similarities and differences","volume":"19","author":"Vetulani","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2011.03.004_b0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(02)00026-X","article-title":"Expression of 5-HT1A receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation","volume":"98","author":"Zhang","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.npep.2011.03.004_b0390","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/jm00165a002","article-title":"Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents","volume":"33","author":"Zimmerman","year":"1990","journal-title":"J. Med. Chem."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417911000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417911000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:40:25Z","timestamp":1741160425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417911000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0143417911000242"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2011.03.004","relation":{},"ISSN":["0143-4179"],"issn-type":[{"type":"print","value":"0143-4179"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}